Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 9
2014 1
2015 8
2016 443
2017 3526
2018 383
2019 5
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3,526 results
Results by year
Filters applied: . Clear all
Page 1
Global epidemiology and burden of HCV infection and HCV-related disease.
Thrift AP, El-Serag HB, Kanwal F. Thrift AP, et al. Nat Rev Gastroenterol Hepatol. 2017 Feb;14(2):122-132. doi: 10.1038/nrgastro.2016.176. Epub 2016 Dec 7. Nat Rev Gastroenterol Hepatol. 2017. PMID: 27924080 Review.
Chronic HCV infection is a global health problem that affects >184 million people worldwide. ...In this Review, we will discuss the global epidemiology and burden of HCV and its complications, as well as the natural history and clinical course of chronic and cure …
Chronic HCV infection is a global health problem that affects >184 million people worldwide. ...In this Review, we will discuss th …
Viral-Associated GN: Hepatitis C and HIV.
Kupin WL. Kupin WL. Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1337-1342. doi: 10.2215/CJN.04320416. Epub 2016 Oct 24. Clin J Am Soc Nephrol. 2017. PMID: 27797895 Free PMC article. Review.
Epidemiologic data show that approximately 25%-30% of all HIV patients are coinfected with HCV and 5%-10% of all HCV patients are coinfected with HIV. This situation can often lead to a challenging differential diagnosis when glomerular disease occurs in this dual-i …
Epidemiologic data show that approximately 25%-30% of all HIV patients are coinfected with HCV and 5%-10% of all HCV patients …
Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.
Grebely J, Applegate TL, Cunningham P, Feld JJ. Grebely J, et al. Expert Rev Mol Diagn. 2017 Dec;17(12):1109-1115. doi: 10.1080/14737159.2017.1400385. Epub 2017 Nov 8. Expert Rev Mol Diagn. 2017. PMID: 29088981 Review.
Areas covered: This commentary explores why point-of-care tests for HCV are needed, what markers of HCV can be measured, methods for sample collection, where HCV testing can occur, and the remaining challenges for HCV point-of-care testing. Expert comm …
Areas covered: This commentary explores why point-of-care tests for HCV are needed, what markers of HCV can be measured, metho …
Profile of Roche's cobas HCV tests.
Kessler HH, Stelzl E. Kessler HH, et al. Expert Rev Mol Diagn. 2017 Apr;17(4):311-319. doi: 10.1080/14737159.2017.1293526. Epub 2017 Feb 22. Expert Rev Mol Diagn. 2017. PMID: 28277143 Review.
Furthermore, the HCV genotype should be assessed prior to treatment initiation. Recently, Roche developed the cobas HCV tests for use on the cobas 6800/8800 Systems and the cobas 4800 System and the cobas HCV genotyping (GT) test for use on the cobas 4800 Sys …
Furthermore, the HCV genotype should be assessed prior to treatment initiation. Recently, Roche developed the cobas HCV tests …
Hepatitis C virus genotypes and subtypes circulating in Mainland China.
Chen Y, Yu C, Yin X, Guo X, Wu S, Hou J. Chen Y, et al. Emerg Microbes Infect. 2017 Nov 1;6(11):e95. doi: 10.1038/emi.2017.77. Emerg Microbes Infect. 2017. PMID: 29089588 Free PMC article.
The hepatitis C virus (HCV) exhibits global genotypic diversity. HCV genotyping plays an important role in epidemiological studies and clinical management. ...Our analyses revealed the comprehensive distribution patterns of HCV genotypes in the general popula …
The hepatitis C virus (HCV) exhibits global genotypic diversity. HCV genotyping plays an important role in epidemiological stu …
Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.
Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB. Devhare PB, et al. J Virol. 2017 Feb 28;91(6):e02225-16. doi: 10.1128/JVI.02225-16. Print 2017 Mar 15. J Virol. 2017. PMID: 28077652 Free PMC article.
Since HCV does not replicate in HSC, we hypothesized that exosomes secreted from HCV-infected hepatocytes activate HSC. ...The higher expression of miR-19a in exosomes was also observed from HCV-infected hepatocytes and in sera of chronic HCV patients …
Since HCV does not replicate in HSC, we hypothesized that exosomes secreted from HCV-infected hepatocytes activate HSC. ...The …
From HCV To HBV Cure.
Schinazi RF, Asselah T. Schinazi RF, et al. Liver Int. 2017 Jan;37 Suppl 1(Suppl 1):73-80. doi: 10.1111/liv.13324. Liver Int. 2017. PMID: 28052627 Free PMC article. Review.
This progress could theorically lead to HCV global elimination making HCV and its consequences a rarity. ...This review will summarize key steps which have been realized for an HCV cure, and discuss the next steps to achieve for an HCV elimination. ...
This progress could theorically lead to HCV global elimination making HCV and its consequences a rarity. ...This review will s …
Glecaprevir/Pibrentasvir: First Global Approval.
Lamb YN. Lamb YN. Drugs. 2017 Oct;77(16):1797-1804. doi: 10.1007/s40265-017-0817-y. Drugs. 2017. PMID: 28929412 Review.
A fixed-dose combination tablet of the hepatitis C virus (HCV) NS3/4A protease inhibitor (PI) glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/pibrentasvir; MAVIRET (EU); MAVYRET (USA)] has been developed by AbbVie. Oral glecaprevir/pibrentasvir 300 …
A fixed-dose combination tablet of the hepatitis C virus (HCV) NS3/4A protease inhibitor (PI) glecaprevir and the HCV NS5A inh …
The neuropsychiatric aspect of the HCV infection.
Więdłocha M, Marcinowicz P, Sokalla D, Stańczykiewicz B. Więdłocha M, et al. Adv Clin Exp Med. 2017 Jan-Feb;26(1):167-175. doi: 10.17219/acem/37787. Adv Clin Exp Med. 2017. PMID: 28397449 Free article. Review.
HCV infection is significantly more prevalent in the population of psychiatric patients, drug addicts and people tending to undertake risky sexual behaviors than in the general population. ...Attention has also been dedicated separately to specific issues, like psychiatric
HCV infection is significantly more prevalent in the population of psychiatric patients, drug addicts and people tending to undertake
Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations.
Antonelli A, Pistello M. Antonelli A, et al. Curr Drug Targets. 2017;18(7):752-755. doi: 10.2174/1389450116666151102095708. Curr Drug Targets. 2017. PMID: 26521772
More than 180 millions of subjects in the world are infected by Hepatitis C Virus (HCV), and about 20% of them with HCV chronic infection progress to cirrhosis. ...Advances in understanding the HCV life cycle, and the inflammatory processes (involving a compl …
More than 180 millions of subjects in the world are infected by Hepatitis C Virus (HCV), and about 20% of them with HCV chroni …
3,526 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page